1. Yu, Jintao, Li, Xiaoying, Zhou, Baosen, Yan, Aihui. 2019. Polymorphisms of the TERT-CLPTM1L Gene Are Associated with Pharynx-Larynx Cancer. In DNA and cell biology, 38, 915-921. doi:10.1089/dna.2019.4744. https://pubmed.ncbi.nlm.nih.gov/31429604/
2. Kol, Inbal, Rishiq, Ahmed, Cohen, Mevaseret, Seidel, Einat, Mandelboim, Ofer. 2023. CLPTM1L is a GPI-anchoring pathway component targeted by HCMV. In The Journal of cell biology, 222, . doi:10.1083/jcb.202207104. https://pubmed.ncbi.nlm.nih.gov/37389656/
3. Ramachandran, Dhanya, Mao, Qianqian, Liao, Dandan, Scholl, Suzy, Dörk, Thilo. 2024. Methylation, Gene Expression, and Risk Genotypes at the TERT-CLPTM1L Locus in Cervical Cancer. In Molecular carcinogenesis, 64, 14-24. doi:10.1002/mc.23822. https://pubmed.ncbi.nlm.nih.gov/39352309/
4. Jia, Jinping, Bosley, Allen D, Thompson, Abbey, Andresson, Thorkell, Amundadottir, Laufey T. 2014. CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. In Cancer research, 74, 2785-95. doi:10.1158/0008-5472.CAN-13-3176. https://pubmed.ncbi.nlm.nih.gov/24648346/
5. Hou, Yunwen, Xue, Feifei, Fu, Yu, Wang, Ruixia, Yuan, Hua. . CLPTM1L Is a Novel Putative Oncogene Promoting Tumorigenesis in Oral Squamous Cell Carcinoma. In Cell transplantation, 30, 9636897211045970. doi:10.1177/09636897211045970. https://pubmed.ncbi.nlm.nih.gov/34586883/
6. Jin, Tianbo, Li, Bin, He, Na, Ding, Yipeng, Yuan, Dongya. 2016. CLPTM1L polymorphism as a protective factor for lung cancer: a case-control study in southern Chinese population. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 10533-8. doi:10.1007/s13277-016-4938-9. https://pubmed.ncbi.nlm.nih.gov/26852039/
7. Li, Hang, Che, Jun, Jiang, Mian, Liu, Weili, Fan, Saijun. 2020. CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells. In Cell communication and signaling : CCS, 18, 152. doi:10.1186/s12964-020-00571-4. https://pubmed.ncbi.nlm.nih.gov/32943060/
智鼠故事 
